Home > Newsletters > International Pharmaceutical Regulatory Monitor > EMA Urges Quick Communication on Drugmaker GMP Failures
International Pharmaceutical Regulatory Monitor
July 2012 | Vol. 40 No. 7
EMA Urges Quick Communication on Drugmaker GMP Failures
The European Medicines Agency (EMA) is stressing the need for timely, coordinated communications between EU member states when one state learns of a drugmaker’s noncompliance with good manufacturing practices (GMPs) from a non-EU country’s regulator or from an international organization, such as the World Health Organization.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.